1. Search Result
Search Result
Results for "

NA

" in MedChemExpress (MCE) Product Catalog:

509

Inhibitors & Agonists

3

Screening Libraries

15

Fluorescent Dye

23

Biochemical Assay Reagents

33

Peptides

1

MCE Kits

1

Inhibitory Antibodies

78

Natural
Products

95

Recombinant Proteins

50

Isotope-Labeled Compounds

15

Antibodies

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W019823
    4-MUNANA
    2 Publications Verification

    Fluorescent Dye Infection Neurological Disease
    4-MUNANA is a substrate of influenza virus neuraminidase (NA) with high selectivity and irreversible reaction. In the enzymatic reaction, 4-MUNANA is hydrolyzed by NA to generate fluorescent 4-methylumbelliferone (4-MU). By detecting the fluorescence intensity of 4-MU, quantitative analysis of NA activity can be achieved. 4-MUNANA can be used in influenza-related research, such as screening NA inhibitors, developing new anti-influenza drugs, and studying the infection mechanism of influenza viruses .
    4-MUNANA
  • HY-N1446B
    Oleic acid sodium
    Maximum Cited Publications
    64 Publications Verification

    Sodium oleate; 9-cis-Octadecenoic acid sodium; 9Z-Octadecenoic acid sodium

    Environmental Pollutants Apoptosis Na+/K+ ATPase Metabolic Disease Cancer
    Sodium oleate (Oleic acid sodium) is an abundant monounsaturated fatty acid sodium . Sodium oleate is a Na +/K + ATPase activator .
    Oleic acid sodium
  • HY-Y1889A

    CMC-NA (MW 250000); CMC-NA (Viscosity:1500-3100 mPa.s)

    Environmental Pollutants Biochemical Assay Reagents Others
    Sodium carboxymethyl cellulose (CMC-Na) (MW 250000) is a sodium salt of carboxymethyl cellulose. Sodium carboxymethyl cellulose has adsorption and corrosion inhibition on low-carbon steel in an acidic medium. Sodium carboxymethyl cellulose can be used as a thickener, paste and barrier agent .
    Sodium carboxymethyl cellulose (MW 250000)
  • HY-N0736
    Coptisine chloride
    10+ Cited Publications

    Indoleamine 2,3-Dioxygenase (IDO) Bacterial Influenza Virus Infection Metabolic Disease Cancer
    Coptisine chloride is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM. Coptisine chloride is a potent H1N1 neuraminidase (NA-1) inhibitor with an IC50 of 104.6?μg/mL and can be used for influenza A (H1N1) infection.
    Coptisine chloride
  • HY-B1039A
    Ambroxol hydrochloride
    3 Publications Verification

    NA-872 hydrochloride

    Glycosidase Autophagy Neurological Disease Metabolic Disease
    Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
    Ambroxol hydrochloride
  • HY-141613

    DOPS-NA

    Liposome Others
    1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium (DOPS-NA) is a ubstitute for Phosphoserine/phosphatidylserine. 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium can be used together with DOPC and DOPE in lipid mixtures for the synthesis of liposomes. 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium can self-assemble into single-layer or double-layer membrane structures, similar to cell membranes, and possesses high membrane fluidity and flexibility. 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine is widely applied in membrane biology, cell membrane research, lipid preparation, and drug delivery systems .
    1,2-Dioleoyl-sn-glycero-3-phospho-L-serine sodium
  • HY-15754
    CGP37157
    5+ Cited Publications

    Na+/Ca2+ Exchanger Neurological Disease Cancer
    CGP37157 is a potent, selective inhibitor of Na +/Ca 2+ exchanger, inhibiting the Na +-induced Ca 2+-release from guinea-pig heart mitochondria, with an IC50 of 0.8 μM.
    CGP37157
  • HY-19693
    Cariporide
    10+ Cited Publications

    HOE-642 Free Base

    Na+/H+ Exchanger (NHE) Cardiovascular Disease Inflammation/Immunology Cancer
    Cariporide (HOE-642) is a selective Na +/H + exchange inhibitor.
    Cariporide
  • HY-75839
    Dronedarone Hydrochloride
    4 Publications Verification

    Potassium Channel Autophagy Cardiovascular Disease
    Dronedarone Hydrochloride is a non-iodinated amiodarone derivative that inhibits Na +, K + and Ca 2+ currents.
    Dronedarone Hydrochloride
  • HY-114252
    Strophanthidin
    1 Publications Verification

    Na+/K+ ATPase Cardiovascular Disease
    Strophanthidin is a naturally available cardiac glycoside . Strophanthidin 0.1 and 1 nmol/L increases and 1~100 μmol/L inhibits the Na+/K+-ATPase activities, but Strophanthidin 10 and 100 nmol/L does not affect Na+/K+-ATPase activities in cardiac sarcolemmal . Strophanthidin increases both diastolic and systolic intracellular Ca 2+ concentration .
    Strophanthidin
  • HY-B1039
    Ambroxol
    3 Publications Verification

    NA-872

    Glycosidase Autophagy Neurological Disease Metabolic Disease
    Ambroxol (NA-872), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
    Ambroxol
  • HY-15515
    SEA0400
    15+ Cited Publications

    Na+/Ca2+ Exchanger Cardiovascular Disease
    SEA0400 is a novel and selective inhibitor of the Na +-Ca 2+ exchanger (NCX), inhibiting Na +-dependent Ca 2+ uptake in cultured neurons, astrocytes, and microglia with IC50s of from 5 to 33 nM.
    SEA0400
  • HY-126831
    SBFI-AM
    3 Publications Verification

    Fluorescent Dye Others
    SBFI-AM is a Na + selective fluorescent indicator. SBFI-AM shows selectivity for Na + over K + with Kd values of 6.7 and 166 mM, respectively (Ex = 340/380 nm; Em = 500 nm) .
    SBFI-AM
  • HY-13719
    Oleandrin
    5 Publications Verification

    PBI-05204

    Na+/K+ ATPase Cancer
    Oleandrin (PBI-05204) inhibits the Na +, K +-ATPase activity with an IC50 of 620 nM.
    Oleandrin
  • HY-19556

    SJ000557733

    Na+/K+ ATPase Parasite Infection
    (+)-SJ733 is an anti-malaria agent which can also inhibit Na +-ATPase PfATP4.
    (+)-SJ733
  • HY-155482
    NA-184
    1 Publications Verification

    Proteasome Neurological Disease
    NA-184 is a selective and brain-penetrant calpain-2 inhibitor with an IC50 of 134 nM for mouse calpain-2. NA-184 has weak inhibitory activity on calpain-1 (IC50 of 2826 nM). NA-184 does not exhibit significant inhibition on a variety of other cysteine-, serine- or metallo-proteases. NA-184 shows significant neuroprotection and can be used for the study of traumatic brain injury (TBI) .
    NA-184
  • HY-13941
    1-Naphthyl PP1
    3 Publications Verification

    1-NA-PP 1

    Src PKD Neurological Disease Inflammation/Immunology Cancer
    1-Naphthyl PP1 (1-NA-PP 1) is a selective inhibitor of src family kinases and Protein Kinase D. 1-Naphthyl PP1 inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively .
    1-Naphthyl PP1
  • HY-103332
    N-Arachidonylglycine
    1 Publications Verification

    NA-Gly

    GlyT Endogenous Metabolite Inflammation/Immunology
    N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration .
    N-Arachidonylglycine
  • HY-P0117
    Tat-NR2B9c
    Maximum Cited Publications
    8 Publications Verification

    Tat-NR2Bct; NA-1

    iGluR NO Synthase Neurological Disease
    Tat-NR2B9c (Tat-NR2Bct; NA-1) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .
    Tat-NR2B9c
  • HY-14818
    Laninamivir
    5+ Cited Publications

    R 125489

    Influenza Virus Infection
    Laninamivir (R 125489) is a potent influenza neuraminidase (NA) inhibitor with IC50s of 0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA (N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2 (p57N2), respectively .
    Laninamivir
  • HY-19273
    Rimeporide
    4 Publications Verification

    EMD-87580

    Na+/H+ Exchanger (NHE) Metabolic Disease
    Rimeporide (EMD-87580) is a potent and selective inhibitor of the Na +/H + exchanger (NHE-1).
    Rimeporide
  • HY-101109
    Sodium ionophore III
    1 Publications Verification

    ETH2120

    Sodium Channel Cardiovascular Disease
    Sodium ionophore III (ETH2120) is a Na + ionophore suitable for the assay of sodium activity in blood, plasma, serum. etc.
    Sodium ionophore III
  • HY-12545
    Brevetoxin-3
    1 Publications Verification

    PbTx-3

    Sodium Channel Inflammation/Immunology
    Brevetoxin-3 (PbTx-3) is a potent allosteric voltage-gated Na + channel activator and has multiple active centers (A-ring lactone, C-42 of R side chain) . Brevetoxin-3 (PbTx-3) has a high affinity to site 5 of the voltage-sensitive Na + channels, inhibits the inactivation of Na + channels and prolongs the mean open time of these channels. Brevetoxin-3 (PbTx-3) repeated exposures can lead to prolonged airway hyperresponsiveness (AHR) and lung inflammation .
    Brevetoxin-3
  • HY-162455

    EAAT Neurological Disease
    NA-014 is an excitatory amino acid transporter 2 (EAAT2)-selective positive allosteric modulator. NA-014 increases EAAT2-mediated glutamate uptake. NA-014 can be used for the research of epilepsy, neuropathic pain, stroke, drugs of abuse disorders .
    NA-014
  • HY-13941B
    1-Naphthyl PP1 hydrochloride
    3 Publications Verification

    1-NA-PP 1 hydrochloride

    Src PKD Neurological Disease Inflammation/Immunology Cancer
    1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) is a selective inhibitor of src family kinases and Protein Kinase D. 1-Naphthyl PP1 hydrochloride inhibits v-Src and c-Fyn, c-Abl, CDK2 and CAMK II with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively .
    1-Naphthyl PP1 hydrochloride
  • HY-145154

    Na+/K+ ATPase Drug Metabolite Cardiovascular Disease Metabolic Disease
    Digoxigenin monodigitoxoside, a metabolite of Digoxin (HY-B1049), belongs to the class of cardenolides. Digoxigenin monodigitoxoside exerts its function by inhibiting Na,K-ATPase. Digoxigenin monodigitoxoside is used for the research of cardiovascular diseases such as congestive heart failure and cardiac arrhythmias .
    Digoxigenin monodigitoxoside
  • HY-17015
    Peramivir trihydrate
    10+ Cited Publications

    RWJ 270201 trihydrate; BCX 1812 trihydrate

    Influenza Virus IKK JNK STAT p38 MAPK ERK Infection Inflammation/Immunology
    Peramivir trihydrate (RWJ-270201 trihydrate) is a highly potent, selective and orally active influenza virus neuraminidase (NA) inhibitor, with IC50 values ranging from 0.9 to 4.3 nM for nine NA subtypes .
    Peramivir trihydrate
  • HY-N0724
    Mesaconitine
    2 Publications Verification

    TNF Receptor Neurological Disease
    Mesaconitine is a nitric oxide synthase activator. Mesaconitine drives extracellular Na + and Ca 2+ influx into endothelial cells, increases intracellular Na + and Ca 2+ concentrations, and triggers nitric oxide release. Mesaconitine is applicable for pain-related research .
    Mesaconitine
  • HY-B0137
    Prilocaine
    1 Publications Verification

    Na+/K+ ATPase Neurological Disease
    Prilocaine, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects .
    Prilocaine
  • HY-15718

    PST2744

    Na+/K+ ATPase Cardiovascular Disease
    Istaroxime (PST2744) is a potent inhibitor of Na +,K +-ATPase with IC50 of 0.11 μM.
    Istaroxime
  • HY-N6745

    Na+/K+ ATPase Apoptosis Infection Cardiovascular Disease
    Citreoviridin, a toxin from Penicillium citreoviride NRRL 2579, inhibits brain synaptosomal Na +/K +-ATPase whereas in microsomes, both Na +/K +-ATPase and Mg 2+-ATPase activities are significantly stimulated in a dose-dependent manner . Citreoviridin inhibits cell proliferation and enhances apoptosis of human umbilical vein endothelial cells .
    Citreoviridin
  • HY-B1039AS

    NA-872-d5 hydrochloride

    Isotope-Labeled Compounds Glycosidase Autophagy Neurological Disease Metabolic Disease
    Ambroxol-d5 (hydrochloride) is the deuterium labeled Ambroxol hydrochloride. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
    Ambroxol-d5 hydrochloride
  • HY-P2660

    GD4K-NA

    Enteropeptidase Others
    Gly-Asp-Asp-Asp-Asp-Lys-β-naphthylamide (GD4K-na) is a substrate for human enteropeptidase (Km: 0.16 mM) .
    Gly-Asp-Asp-Asp-Asp-Lys-β-naphthylamide
  • HY-DY1034

    Fluorescent Dye Infection Neurological Disease
    4-MUNANA (solution) is a substrate of influenza virus neuraminidase (NA) with high selectivity and irreversible reaction. In the enzymatic reaction, 4-MUNANA is hydrolyzed by NA to generate fluorescent 4-methylumbelliferone (4-MU). By detecting the fluorescence intensity of 4-MU, quantitative analysis of NA activity can be achieved. 4-MUNANA can be used in influenza-related research, such as screening NA inhibitors, developing new anti-influenza drugs, and studying the infection mechanism of influenza viruses .
    Solvent and Concentration: Sterile water: 10 mM
    4-MUNANA (solution)
  • HY-106150B
    Eniporide hydrochloride
    1 Publications Verification

    EMD-96785 hydrochloride

    Na+/H+ Exchanger (NHE) Cardiovascular Disease
    Eniporide hydrochloride (EMD-96785 hydrochloride) is a potent Na +/H + exchange inhibitor.
    Eniporide hydrochloride
  • HY-16952A
    Bepridil hydrochloride hydrate
    5+ Cited Publications

    (±)-Bepridil hydrochloride hydrate; Org 5730 hydrochloride hydrate

    Calcium Channel Cardiovascular Disease
    Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a non-selective, long-acting Ca + channel antagonist and Na +, K + channel inhibitor, with antianginal and type I antiarrhythmic effects. Bepridil hydrochloride hydrate also acts as a cardiac Na +/Ca2 + exchange (NCX1) inhibitor. Bepridil hydrochloride hydrate can be used for the research of cardiovascular disorders .
    Bepridil hydrochloride hydrate
  • HY-B1604

    2-Chloroprocaine hydrochloride

    Na+/K+ ATPase Neurological Disease
    Chloroprocaine hydrochloride (2-Chloroprocaine hydrochloride) is a potent inhibitor of Na,K-ATPase activity with an IC50 of 13 mM. Chloroprocaine hydrochloride blocks peripheral nerve .
    Chloroprocaine hydrochloride
  • HY-B1039AR

    NA-872 hydrochloride (Standard)

    Reference Standards Glycosidase Autophagy Neurological Disease Metabolic Disease
    Ambroxol (hydrochloride) (Standard) is the analytical standard of Ambroxol (hydrochloride). This product is intended for research and analytical applications. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
    Ambroxol hydrochloride (Standard)
  • HY-W718136

    GlcN6P-NA

    Biochemical Assay Reagents Others
    D-Glucosamine 6-phosphate (sodium) (GlcN6P-Na) is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology, and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-glycan recognition, and the role of glycans in biological systems. This field is closely related to basic research, biomedicine, and biotechnology .
    D-Glucosamine 6-phosphate sodium
  • HY-D1760

    Fluorescent Dye Others
    SBFI is a cell-impermeant, fluorescent Na + indicator dye. SBFI is excited at 340 nm and the fluorophore emission is collected at 450 nm . SBFI selective for Na + over K + with Kd values of 20 and 120 mM for these ions, respectively. .
    Sodium-binding benzofuran isophthalate
  • HY-P0117A
    Tat-NR2B9c TFA
    Maximum Cited Publications
    8 Publications Verification

    Tat-NR2Bct TFA; NA-1 TFA

    iGluR NO Synthase Neurological Disease
    Tat-NR2B9c TFA (Tat-NR2Bct TFA) is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy .
    Tat-NR2B9c TFA
  • HY-N10627

    Endogenous Metabolite Others
    NA2 Glycan is NA2 N-linked oligosaccharide. NA2 is the asialo-substructure of A2 glycan. NA2 glycan can be isolated from mammalian serum glycoproteins, such as serum IgG .
    NA2 Glycan
  • HY-B1604A

    2-Chloroprocaine

    Na+/K+ ATPase Neurological Disease
    Chloroprocaine (2-Chloroprocaine) is a potent inhibitor of Na,K-ATPase activity with an IC50 of 13 mM. Chloroprocaine blocks peripheral nerve .
    Chloroprocaine
  • HY-137172

    Sodium Channel Others
    ETH 157 is a neutral sodium-selective carrier. ETH 157 exhibits sufficient Na +/K + selectivity and enhanced Na +/Ca 2+ selectivity, making it suitable for the detection of extracellular Na + activity .
    ETH 157
  • HY-124404

    Aryl Hydrocarbon Receptor Na+/K+ ATPase Prostaglandin Receptor Inflammation/Immunology
    12(R)-HETE is a CYP-dependent arachidonic acid metabolite that acts as a proinflammatory lipid mediator. 12 (R)-HETE widely exists in various tissues including the eye, skin and liver. In the cornea, 12(R)-HETE is metabolized via pathways such as β-oxidation into the precursor of 12(R)-HETrE. Without direct receptor binding, 12(R)-HETE indirectly activates AHR-mediated target gene transcription, while inhibiting the enzymatic activity of Na+,K+-ATPase and the intracellular calcium elevation induced by TP agonists. 12(R)-HETE also possesses multiple physiological effects such as chemotaxis, proangiogenesis, vasodilation, natriuresis, diuresis and intraocular pressure reduction, and can be widely used in studies related to psoriasis, inflammatory skin diseases and ocular inflammation .
    12(R)-HETE
  • HY-N6574

    Na+/K+ ATPase Cardiovascular Disease Neurological Disease Metabolic Disease
    Marinobufogenin is a strong inhibitor of Na +/K + ATPase that has been identified in mammalian plasma .
    Marinobufogenin
  • HY-15515R

    Na+/Ca2+ Exchanger Reference Standards Cardiovascular Disease
    SEA0400 (Standard) is the analytical standard of SEA0400. This product is intended for research and analytical applications. SEA0400 is a novel and selective inhibitor of the Na+-Ca2+ exchanger (NCX), inhibiting Na+-dependent Ca2+ uptake in cultured neurons, astrocytes, and microglia with IC50s of from 5 to 33 nM.
    SEA0400 (Standard)
  • HY-B0137A
    Prilocaine hydrochloride
    1 Publications Verification

    Na+/K+ ATPase Neurological Disease
    Prilocaine hydrochloride, an amino amide, is a Na/K-ATPase inhibitor. Prilocaine has neurotoxic effects .
    Prilocaine hydrochloride
  • HY-132133

    Sodium Channel Neurological Disease Inflammation/Immunology
    Nav1.8-IN-1 (Compound 31) is a potent inhibitor of Na(v)1.8 sodium channel. Nav1.8-IN-1 has the potential for the research of inflammatory and neuropathic pain .
    Nav1.8-IN-1
  • HY-172515

    Influenza Virus Virus Protease Drug Isomer Infection
    ent-Oseltamivir, the enantiomer of Oseltamivir (HY-13317), is a neuraminidase (NA) of influenza virus inhibitor. ent-Oseltamivir is promising for research of influenza virus infections .
    ent-Oseltamivir

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: